Wastewater from many sectors that contains hazardous organic pollutants exacerbates environmental contamination. Consequently, outstanding photocatalytic substances that can successfully degrade hazardous substances are needed to provide pollution-free water. From this perspective, zinc oxide/g-C₃N₄-based composites are desirable due to their low cost, strong reactivity, and environmental friendliness. So, in the current investigation, sequences of Mn/g-C₃N₄/ZnO (Mn/GZ) and Ni/g-C₃N₄/ZnO (Ni/GZ) nanocomposites (NCs) containing different concentrations (wt.%) of g-C₃N₄ were made via the co-precipitation process. The chemical makeup and morphological characteristics of the produced composites were ascertained via the techniques of transmission electron microscopy (TEM), scanning electron microscopy (SEM), energy-dispersive X-ray (EDX), Fourier transform infrared (FTIR), photoluminescence (PL), and UV spectrophotometry. Methyl orange (MO) and Eriochrome Black T (EBT) dyes were used as target pollutants to assess the composite materials’ photocatalytic effectiveness. Compared to g-C₃N₄/ZnO and g-C₃N₄, the produced Mn/GZ and Ni/GZ NCs displayed better photocatalytic activity. The improved photocatalytic efficiency of the Ni/GZ and Mn/GZ NCs might be credited to synergistic interactions at the g-C₃N₄ and ZnO interface that result in a more efficient separation and conduction of photo-induced charges. Furthermore, the Ni/Mn atoms act as the facilitators to improve electron–hole pair separation and conduction in NCs. The nanocomposites were found to be incredibly stable, with consistently high dye decoloration efficiency over five catalytic cycles. Hence, Ni/GZ and Mn/GZ could potentially be very effective and adaptable photocatalysts for the photocatalytic decoloration of wastewater pollutants.

The incidence of stroke plays the foremost role in the genesis of central neuropathic pain. Central post-stroke pain (CPSP) is a central pain arising from a vascular lesion in the central nervous system that elicits somatosensory deficits, often contralateral to stroke lesions. It is expressed as continuous or intermittent pain accompanied by sensory abnormalities like dysesthesia and allodynia. CPSP remains de-emphasized due to the variation in onset and diversity in symptoms, besides the difficulty of distinguishing it from other post-stroke pains, often referred to as a diagnosis of exclusion. Spinothalamic dysfunction, disinhibition of the medial thalamus, and neuronal hyperexcitability combined with deafferentation in thalamocortical regions are the mechanisms underlying central pain, which play a significant role in the pathogenesis of CPSP. The treatment regimen for CPSP seems to be perplexed in nature; however, based on available studies, amitriptyline and lamotrigine are denoted as first-line medications and non-pharmacological choices may be accounted for cases intractable to pharmacotherapy. This review attempts to provide an overview of the mechanisms, existing management approaches, and emerging targets of CPSP. A profound understanding of CPSP aids in optimizing the quality of life among stroke sufferers and facilitates further research to develop newer therapeutic agents for managing CPSP.

Phoenix dactylifera, commonly called date palm, has great importance as a fruiting plant. The hot methanolic extract of date seeds (HMEDSE), was further fractionated into three fractions (F1, F2, and F3) through column chromatography. The three fractions were composed of various bioactive constituents which was analysed through GC-MS and FT-IR analysis. The results revealed remarkable antibacterial properties of crude HMEDSE against various pathogenic microorganisms affecting humans. The spectrum of activity of HMEDSE against various human pathogenic bacteria showed the following sequence based on its efficacy, Escherichia coli (17.6 ± 2.5 mm), Klebsiella pneumoniae (16.3 ± 2.5 mm), Staphylococcus aureus (16.3 ± 1.5 mm), Streptococcus pyogenes (15 ± 2.6 mm), Pseudomonas aeruginosa (15 ± 2 mm), and lastly, Bacillus subtilis (14.3 ± 2 mm). Furthermore, HMEDSE exhibited cytotoxicity, with an IC₅₀ of 73.5 ± 0.5 µg/mL against MCF-7 ATCC breast cancer cells, leading to gradual apoptosis.